Fresenius Medical Care was founded in 1996 and operates in Bad Homburg Vor Der Hoehe, Germany. It engages in the sector 'Hospital' (ISIC: 8610). Factors which play a role in the growth of this ...

Alyx is designed to help optimize your bottom line with reduced labor and error related costs and the ability to increase collection of high value components.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aurora™ is the automated system that streamlines plasma collection, producing virtually cell-free plasma and providing an improved experience for both operators and donors. The system separates ...

The best logo maker helps you craft the right branding for your business - even if you've never designed a logo before. Our team of expert reviewers have tested the best free logo makers and the ...

The company has a new logo, designed by Pentagram, that looks incredibly plain — especially compared to previous iterations of the logo that featured a rakish slant, two shades of blue ...

Fresenius Medical Care AG & Co. KGaA FMS is well-poised for growth on the back of a broad range of dialysis products and services, and a solid global foothold. However, stiff competition remains a ...

Analyst Marianne Bulot from Bank of America Securities maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) and keeping the price target at €30.00.

(RTTNews) - German healthcare major Fresenius SE & Co. KGaA (FSNUF.PK, FSNPF.PK) announced Monday that its operating company Fresenius Kabi transferred the ownership of its subsidiary Laboratorio ...

Berenberg Bank analyst Victoria Lambert maintained a Buy rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) today and set a price target of €47.00. The company’s shares ...

The global peritoneal dialysis market is set to grow from USD 9.58 billion in 2024 to USD 12.70 billion by 2029, reflecting a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...